Investor Presentation First Nine Months of 2023 slide image

Investor Presentation First Nine Months of 2023

19 Investor presentation First nine months of 2023 Appendix Novo Nordisk corporate strategy Diabetes care GLP-1 Insulin Obesity care 20 34 43 51 56 Rare disease 81 Other serious chronic diseases 94 Regional information 112 Financials 142 Sustainability 152
View entire presentation